Gene · 10481
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells. | Cancers (Basel) | 2023 | 37046780 | PubTator, text mining | PubMed |
| High-Risk Pedigree Study Identifies LRBA (rs62346982) as a Likely Predisposition Variant for Prostate Cancer. | Cancers (Basel) | 2023 | 37046747 | PubTator, text mining | PubMed |
| Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative. | Cancers (Basel) | 2023 | 37046591 | PubTator, text mining | PubMed |
| Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. | Nat Cancer | 2023 | 37038004 | PubTator, text mining | PubMed |
| The role of integrin family in bone metabolism and tumor bone metastasis. | Cell Death Discov | 2023 | 37037822 | PubTator, text mining | PubMed |
| Identification of endothelial-related molecular subtypes for bladder cancer patients. | Front Oncol | 2023 | 37025597 | PubTator, text mining | PubMed |
| Molecular basis and therapeutic targets in prostate cancer: A comprehensive review. | Biomol Biomed | 2023 | 37021836 | PubTator, text mining | PubMed |
| Circular RNA circ-TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR-452-5p/DAG1 axis. | Mol Oncol | 2023 | 37014625 | PubTator, text mining | PubMed |
| The role of demethylase AlkB homologs in cancer. | Front Oncol | 2023 | 37007161 | PubTator, text mining | PubMed |
| Endothelial depletion of Atg7 triggers astrocyte-microvascular disassociation at blood-brain barrier. | J Cell Biol | 2023 | 36995368 | PubTator, text mining | PubMed |
| Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial. | EClinicalMedicine | 2023 | 36992863 | PubTator, text mining | PubMed |
| Let's Go 3D! New Generation of Models for Evaluating Drug Response and Resistance in Prostate Cancer. | Int J Mol Sci | 2023 | 36982368 | PubTator, text mining | PubMed |
| Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients. | J Urol | 2023 | 36974724 | PubTator, text mining | PubMed |
| Gene family expansion and functional diversification of chitinase and chitin synthase genes in Atlantic salmon (Salmo salar). | G3 (Bethesda) | 2023 | 36972305 | PubTator, text mining | PubMed |
| Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer. | Clin Cancer Res | 2023 | 36939530 | PubTator, text mining | PubMed |
| A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer. | Front Oncol | 2023 | 36937454 | PubTator, text mining | PubMed |
| Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 | 36937425 | PubTator, text mining | PubMed |
| Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. | NPJ Breast Cancer | 2023 | 36928216 | PubTator, text mining | PubMed |
| From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer. | Front Genet | 2023 | 36911405 | PubTator, text mining | PubMed |
| Effects of Helicobacter pylori on the expression of the FTO gene and its biological role in gastric cancer. | Oncol Lett | 2023 | 36909372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10481/papers?page=16